APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Mono Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Mono Vaccine Market Outlook and Growth Opportunities 2026

Report ID 174014080422 December 2025194 pages

Choose your research edition.

Industry ResearchMono Vaccine Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Mono Vaccine Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Mono Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mono Vaccine Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Mono Vaccine Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Mono Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Mono Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Mono Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Mono Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Mono Vaccine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Mono Vaccine market include GSK, Merck, Pfizer, Serum Institute of India, Sanofi Pasteur MSD, Sanofi Pasteur, CNBG and Biokangtai, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Mono Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Mono Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Mono Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Mono Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Mono Vaccine Segment by Company

GSK

Merck

Pfizer

Serum Institute of India

Sanofi Pasteur MSD

Sanofi Pasteur

CNBG

Biokangtai

Mono Vaccine Segment by Type

Hepatitis Vaccine

Yellow Fever Vaccine

Cholera Vaccine

Meningococcal Vaccine

Japanese Encephalitis Vaccine

Other

Mono Vaccine Segment by Application

Adults

Children

Mono Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Mono Vaccine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Mono Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Mono Vaccine significant trends, drivers, influence factors in global and regions.

6. To analyze Mono Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mono Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mono Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mono Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Mono Vaccine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Mono Vaccine industry.

Chapter 3: Detailed analysis of Mono Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Mono Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Mono Vaccine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Mono Vaccine Industry Trends Table 2. Mono Vaccine Industry Drivers Table 3. Mono Vaccine Industry Opportunities and Challenges Table 4. Mono Vaccine Industry Restraints Table 5. Global Mono Vaccine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Mono Vaccine Revenue Share by Company (2021-2026) Table 7. Global Mono Vaccine Sales Volume by Company (k units) & (2021-2026) Table 8. Global Mono Vaccine Sales Volume Share by Company (2021-2026) Table 9. Global Mono Vaccine Average Price (US$/unit) of Company (2021-2026) Table 10. Global Mono Vaccine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Mono Vaccine Key Company Manufacturing Base & Headquarters Table 12. Global Mono Vaccine Company, Product Type & Application Table 13. Global Mono Vaccine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Mono Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Hepatitis Vaccine Table 18. Significant Companies of Yellow Fever Vaccine Table 19. Significant Companies of Cholera Vaccine Table 20. Significant Companies of Meningococcal Vaccine Table 21. Significant Companies of Japanese Encephalitis Vaccine Table 22. Significant Companies of Other Table 23. Global Mono Vaccine Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Mono Vaccine Sales Volume by Type (2021-2026) & (k units) Table 25. Global Mono Vaccine Sales Volume by Type (2027-2032) & (k units) Table 26. Global Mono Vaccine Sales Volume Share by Type (2021-2026) Table 27. Global Mono Vaccine Sales Volume Share by Type (2027-2032) Table 28. Global Mono Vaccine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Mono Vaccine Sales Value by Type (2021-2026) & (US$ Million) Table 30. Global Mono Vaccine Sales Value by Type (2027-2032) & (US$ Million) Table 31. Global Mono Vaccine Sales Value Share by Type (2021-2026) Table 32. Global Mono Vaccine Sales Value Share by Type (2027-2032) Table 33. Significant Companies of Adults Table 34. Significant Companies of Children Table 35. Global Mono Vaccine Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Mono Vaccine Sales Volume by Application (2021-2026) & (k units) Table 37. Global Mono Vaccine Sales Volume by Application (2027-2032) & (k units) Table 38. Global Mono Vaccine Sales Volume Share by Application (2021-2026) Table 39. Global Mono Vaccine Sales Volume Share by Application (2027-2032) Table 40. Global Mono Vaccine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Mono Vaccine Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Mono Vaccine Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Mono Vaccine Sales Value Share by Application (2021-2026) Table 44. Global Mono Vaccine Sales Value Share by Application (2027-2032) Table 45. Global Mono Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 46. Global Mono Vaccine Sales by Region (2021-2026) & (k units) Table 47. Global Mono Vaccine Sales Market Share by Region (2021-2026) Table 48. Global Mono Vaccine Sales by Region (2027-2032) & (k units) Table 49. Global Mono Vaccine Sales Market Share by Region (2027-2032) Table 50. Global Mono Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Mono Vaccine Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Mono Vaccine Sales Value Share by Region (2021-2026) Table 53. Global Mono Vaccine Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Mono Vaccine Sales Value Share by Region (2027-2032) Table 55. Global Mono Vaccine Market Average Price (US$/unit) by Region (2021-2026) Table 56. Global Mono Vaccine Market Average Price (US$/unit) by Region (2027-2032) Table 57. Global Mono Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 58. Global Mono Vaccine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Mono Vaccine Sales by Country (2021-2026) & (k units) Table 60. Global Mono Vaccine Sales Market Share by Country (2021-2026) Table 61. Global Mono Vaccine Sales by Country (2027-2032) & (k units) Table 62. Global Mono Vaccine Sales Market Share by Country (2027-2032) Table 63. Global Mono Vaccine Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Mono Vaccine Sales Value Market Share by Country (2021-2026) Table 65. Global Mono Vaccine Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Mono Vaccine Sales Value Market Share by Country (2027-2032) Table 67. GSK Company Information Table 68. GSK Business Overview Table 69. GSK Mono Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. GSK Mono Vaccine Product Portfolio Table 71. GSK Recent Development Table 72. Merck Company Information Table 73. Merck Business Overview Table 74. Merck Mono Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Merck Mono Vaccine Product Portfolio Table 76. Merck Recent Development Table 77. Pfizer Company Information Table 78. Pfizer Business Overview Table 79. Pfizer Mono Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Pfizer Mono Vaccine Product Portfolio Table 81. Pfizer Recent Development Table 82. Serum Institute of India Company Information Table 83. Serum Institute of India Business Overview Table 84. Serum Institute of India Mono Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Serum Institute of India Mono Vaccine Product Portfolio Table 86. Serum Institute of India Recent Development Table 87. Sanofi Pasteur MSD Company Information Table 88. Sanofi Pasteur MSD Business Overview Table 89. Sanofi Pasteur MSD Mono Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Sanofi Pasteur MSD Mono Vaccine Product Portfolio Table 91. Sanofi Pasteur MSD Recent Development Table 92. Sanofi Pasteur Company Information Table 93. Sanofi Pasteur Business Overview Table 94. Sanofi Pasteur Mono Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Sanofi Pasteur Mono Vaccine Product Portfolio Table 96. Sanofi Pasteur Recent Development Table 97. CNBG Company Information Table 98. CNBG Business Overview Table 99. CNBG Mono Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. CNBG Mono Vaccine Product Portfolio Table 101. CNBG Recent Development Table 102. Biokangtai Company Information Table 103. Biokangtai Business Overview Table 104. Biokangtai Mono Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Biokangtai Mono Vaccine Product Portfolio Table 106. Biokangtai Recent Development Table 107. Key Raw Materials Table 108. Raw Materials Key Suppliers Table 109. Mono Vaccine Distributors List Table 110. Mono Vaccine Customers List Table 111. Research Programs/Design for This Report Table 112. Authors List of This Report Table 113. Secondary Sources Table 114. Primary Sources List of Figures Figure 1. Mono Vaccine Product Image Figure 2. Global Mono Vaccine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mono Vaccine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Mono Vaccine Sales (2021-2032) & (k units) Figure 5. Global Mono Vaccine Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Mono Vaccine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Hepatitis Vaccine Image Figure 10. Yellow Fever Vaccine Image Figure 11. Cholera Vaccine Image Figure 12. Meningococcal Vaccine Image Figure 13. Japanese Encephalitis Vaccine Image Figure 14. Other Image Figure 15. Global Mono Vaccine Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Mono Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 17. Global Mono Vaccine Sales Volume Share by Type (2021-2032) Figure 18. Global Mono Vaccine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Mono Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Mono Vaccine Sales Value Share by Type (2021-2032) Figure 21. Adults Image Figure 22. Children Image Figure 23. Global Mono Vaccine Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Mono Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Mono Vaccine Sales Volume Share by Application (2021-2032) Figure 26. Global Mono Vaccine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Mono Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Mono Vaccine Sales Value Share by Application (2021-2032) Figure 29. Global Mono Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 30. Global Mono Vaccine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Mono Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Mono Vaccine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Mono Vaccine Sales Value (2021-2032) & (US$ Million) Figure 34. North America Mono Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Mono Vaccine Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Mono Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Mono Vaccine Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Mono Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Mono Vaccine Sales Value (2021-2032) & (US$ Million) Figure 40. South America Mono Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Mono Vaccine Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Mono Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Mono Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Mono Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Mono Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Mono Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Mono Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Mono Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Mono Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Mono Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Mono Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Mono Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Mono Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Mono Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Mono Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Mono Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Mono Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Mono Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Mono Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Mono Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Mono Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Mono Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Mono Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Mono Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Mono Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Mono Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Mono Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Mono Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Mono Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Mono Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Mono Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Mono Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Mono Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Mono Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Mono Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Mono Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Mono Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Mono Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Mono Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Mono Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Mono Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Mono Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Mono Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Mono Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Mono Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Mono Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Mono Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Mono Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Mono Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Mono Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Mono Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Mono Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Mono Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Mono Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Mono Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Mono Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Mono Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Mono Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Mono Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Mono Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Mono Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Mono Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Mono Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Mono Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Mono Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Mono Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Mono Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Mono Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Mono Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Mono Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Mono Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Mono Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Mono Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Mono Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Mono Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Mono Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Mono Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Mono Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Mono Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Mono Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Mono Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Mono Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Mono Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Mono Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Mono Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Mono Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Mono Vaccine Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Mono Vaccine Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Hepatitis Vaccine
  • Yellow Fever Vaccine
  • Cholera Vaccine
  • Meningococcal Vaccine
  • Japanese Encephalitis Vaccine
  • Other
Applications
  • Adults
  • Children
Companies covered
  • GSK
  • Merck
  • Pfizer
  • Serum Institute of India
  • Sanofi Pasteur MSD
  • Sanofi Pasteur
  • CNBG
  • Biokangtai

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Mono Vaccine Sales Value (2021-2032)
  4. 1.2.2 Global Mono Vaccine Sales Volume (2021-2032)
  5. 1.2.3 Global Mono Vaccine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Mono Vaccine Market Dynamics
  1. 2.1 Mono Vaccine Industry Trends
  2. 2.2 Mono Vaccine Industry Drivers
  3. 2.3 Mono Vaccine Industry Opportunities and Challenges
  4. 2.4 Mono Vaccine Industry Restraints
3 Mono Vaccine Market by Company
  1. 3.1 Global Mono Vaccine Company Revenue Ranking in 2025
  2. 3.2 Global Mono Vaccine Revenue by Company (2021-2026)
  3. 3.3 Global Mono Vaccine Sales Volume by Company (2021-2026)
  4. 3.4 Global Mono Vaccine Average Price by Company (2021-2026)
  5. 3.5 Global Mono Vaccine Company Ranking (2024-2026)
  6. 3.6 Global Mono Vaccine Company Manufacturing Base and Headquarters
  7. 3.7 Global Mono Vaccine Company Product Type and Application
  8. 3.8 Global Mono Vaccine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Mono Vaccine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Mono Vaccine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Mono Vaccine Market by Type
  1. 4.1 Mono Vaccine Type Introduction
  2. 4.1.1 Hepatitis Vaccine
  3. 4.1.2 Yellow Fever Vaccine
  4. 4.1.3 Cholera Vaccine
  5. 4.1.4 Meningococcal Vaccine
  6. 4.1.5 Japanese Encephalitis Vaccine
  7. 4.1.6 Other
  8. 4.2 Global Mono Vaccine Sales Volume by Type
  9. 4.2.1 Global Mono Vaccine Sales Volume by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Mono Vaccine Sales Volume by Type (2021-2032)
  11. 4.2.3 Global Mono Vaccine Sales Volume Share by Type (2021-2032)
  12. 4.3 Global Mono Vaccine Sales Value by Type
  13. 4.3.1 Global Mono Vaccine Sales Value by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Mono Vaccine Sales Value by Type (2021-2032)
  15. 4.3.3 Global Mono Vaccine Sales Value Share by Type (2021-2032)
5 Mono Vaccine Market by Application
  1. 5.1 Mono Vaccine Application Introduction
  2. 5.1.1 Adults
  3. 5.1.2 Children
  4. 5.2 Global Mono Vaccine Sales Volume by Application
  5. 5.2.1 Global Mono Vaccine Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Mono Vaccine Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Mono Vaccine Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Mono Vaccine Sales Value by Application
  9. 5.3.1 Global Mono Vaccine Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Mono Vaccine Sales Value by Application (2021-2032)
  11. 5.3.3 Global Mono Vaccine Sales Value Share by Application (2021-2032)
6 Mono Vaccine Regional Sales and Value Analysis
  1. 6.1 Global Mono Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Mono Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Mono Vaccine Sales by Region: 2021-2026
  4. 6.2.2 Global Mono Vaccine Sales by Region (2027-2032)
  5. 6.3 Global Mono Vaccine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Mono Vaccine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Mono Vaccine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Mono Vaccine Sales Value by Region (2027-2032)
  9. 6.5 Global Mono Vaccine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Mono Vaccine Sales Value (2021-2032)
  12. 6.6.2 North America Mono Vaccine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Mono Vaccine Sales Value (2021-2032)
  15. 6.7.2 Europe Mono Vaccine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Mono Vaccine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Mono Vaccine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Mono Vaccine Sales Value (2021-2032)
  21. 6.9.2 South America Mono Vaccine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Mono Vaccine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Mono Vaccine Sales Value Share by Country, 2025 VS 2032
7 Mono Vaccine Country-level Sales and Value Analysis
  1. 7.1 Global Mono Vaccine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Mono Vaccine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Mono Vaccine Sales by Country (2021-2032)
  4. 7.3.1 Global Mono Vaccine Sales by Country (2021-2026)
  5. 7.3.2 Global Mono Vaccine Sales by Country (2027-2032)
  6. 7.4 Global Mono Vaccine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Mono Vaccine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Mono Vaccine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Mono Vaccine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Mono Vaccine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Mono Vaccine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Mono Vaccine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Mono Vaccine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Mono Vaccine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Mono Vaccine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Mono Vaccine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Mono Vaccine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Mono Vaccine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Mono Vaccine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Mono Vaccine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Mono Vaccine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Mono Vaccine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Mono Vaccine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Mono Vaccine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Mono Vaccine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Mono Vaccine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Mono Vaccine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Mono Vaccine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Mono Vaccine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Mono Vaccine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Mono Vaccine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Mono Vaccine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Mono Vaccine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Mono Vaccine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Mono Vaccine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Mono Vaccine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Mono Vaccine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Mono Vaccine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Mono Vaccine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Mono Vaccine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Mono Vaccine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Mono Vaccine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Mono Vaccine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Mono Vaccine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Mono Vaccine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Mono Vaccine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Mono Vaccine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Mono Vaccine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Mono Vaccine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Mono Vaccine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Mono Vaccine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Mono Vaccine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Mono Vaccine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Mono Vaccine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Mono Vaccine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Mono Vaccine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Mono Vaccine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Mono Vaccine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Mono Vaccine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Mono Vaccine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Mono Vaccine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Mono Vaccine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Mono Vaccine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Mono Vaccine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Mono Vaccine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Mono Vaccine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Mono Vaccine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Mono Vaccine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Mono Vaccine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Mono Vaccine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Mono Vaccine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Mono Vaccine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Mono Vaccine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Mono Vaccine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Mono Vaccine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Mono Vaccine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Mono Vaccine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Mono Vaccine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Mono Vaccine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Mono Vaccine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Mono Vaccine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Mono Vaccine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Mono Vaccine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Mono Vaccine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Mono Vaccine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Mono Vaccine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Mono Vaccine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Mono Vaccine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Mono Vaccine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Mono Vaccine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Mono Vaccine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Mono Vaccine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 GSK
  2. 8.1.1 GSK Company Information
  3. 8.1.2 GSK Business Overview
  4. 8.1.3 GSK Mono Vaccine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 GSK Mono Vaccine Product Portfolio
  6. 8.1.5 GSK Recent Developments
  7. 8.2 Merck
  8. 8.2.1 Merck Company Information
  9. 8.2.2 Merck Business Overview
  10. 8.2.3 Merck Mono Vaccine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Merck Mono Vaccine Product Portfolio
  12. 8.2.5 Merck Recent Developments
  13. 8.3 Pfizer
  14. 8.3.1 Pfizer Company Information
  15. 8.3.2 Pfizer Business Overview
  16. 8.3.3 Pfizer Mono Vaccine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Mono Vaccine Product Portfolio
  18. 8.3.5 Pfizer Recent Developments
  19. 8.4 Serum Institute of India
  20. 8.4.1 Serum Institute of India Company Information
  21. 8.4.2 Serum Institute of India Business Overview
  22. 8.4.3 Serum Institute of India Mono Vaccine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Serum Institute of India Mono Vaccine Product Portfolio
  24. 8.4.5 Serum Institute of India Recent Developments
  25. 8.5 Sanofi Pasteur MSD
  26. 8.5.1 Sanofi Pasteur MSD Company Information
  27. 8.5.2 Sanofi Pasteur MSD Business Overview
  28. 8.5.3 Sanofi Pasteur MSD Mono Vaccine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Sanofi Pasteur MSD Mono Vaccine Product Portfolio
  30. 8.5.5 Sanofi Pasteur MSD Recent Developments
  31. 8.6 Sanofi Pasteur
  32. 8.6.1 Sanofi Pasteur Company Information
  33. 8.6.2 Sanofi Pasteur Business Overview
  34. 8.6.3 Sanofi Pasteur Mono Vaccine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Sanofi Pasteur Mono Vaccine Product Portfolio
  36. 8.6.5 Sanofi Pasteur Recent Developments
  37. 8.7 CNBG
  38. 8.7.1 CNBG Company Information
  39. 8.7.2 CNBG Business Overview
  40. 8.7.3 CNBG Mono Vaccine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 CNBG Mono Vaccine Product Portfolio
  42. 8.7.5 CNBG Recent Developments
  43. 8.8 Biokangtai
  44. 8.8.1 Biokangtai Company Information
  45. 8.8.2 Biokangtai Business Overview
  46. 8.8.3 Biokangtai Mono Vaccine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Biokangtai Mono Vaccine Product Portfolio
  48. 8.8.5 Biokangtai Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Mono Vaccine Value Chain Analysis
  2. 9.1.1 Mono Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Mono Vaccine Sales Mode & Process
  6. 9.2 Mono Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Mono Vaccine Distributors
  9. 9.2.3 Mono Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst